Ovarian Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Ovarian Cancer, including details on symptoms, causes, treatment, information.

Volume 3 (2006), Issue 1 (January)

1. Cathepsin B and its interacting proteins, bikunin and TSRC1, correlate with TNF-induced apoptosis of ovarian cancer cells OV-90.
   FEBS Lett, 580(1): 245-50. [Abstract] [Full-text]
2. Intraperitoneal cisplatin and paclitaxel in ovarian cancer.
   N Engl J Med, 354(1): 34-43. [Abstract] [Full-text]
3. Ligands to FGF receptor 2-IIIb induce proliferation, motility, protection from cell death and cytoskeletal rearrangements in epithelial ovarian cancer cell lines.
   Growth Factors, 24(1): 45-53. [Abstract] [Full-text]
4. Antitumor effect of E1A in ovarian cancer by cytoplasmic sequestration of activated ERK by PEA15.
   Oncogene, 25(1): 79-90. [Abstract] [Full-text]
5. Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.
   Cancer Chemother Pharmacol, 57(4): 491-9. [Abstract] [Full-text]
6. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
   N Engl J Med, 354(3): 261-9. [Abstract] [Full-text]
7. Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays.
   Cancer Res, 66(2): 1181-90. [Abstract] [Full-text]
8. Activity of the adenoviral E1A deletion mutant dl922-947 in ovarian cancer: comparison with E1A wild-type viruses, bioluminescence monitoring, and intraperitoneal delivery in icodextrin.
   Cancer Res, 66(2): 989-98. [Abstract] [Full-text]
9. Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment.
   Cancer Res, 66(2): 936-43. [Abstract] [Full-text]
10. High throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancer.
    Nucleic Acids Res, 34(2): 555-63. [Abstract] [Full-text]
11. Contribution of an unidentified sodium-dependent nucleoside transport system to the uptake and cytotoxicity of anthracycline in mouse M5076 ovarian sarcoma cells.
    Biochem Pharmacol, 71(5): 565-73. [Abstract] [Full-text]
12. From gene profiling to diagnostic markers: IL-18 and FGF-2 complement CA125 as serum-based markers in epithelial ovarian cancer.
    Int J Cancer, 118(7): 1750-8. [Abstract] [Full-text]
13. Optimal selection of individuals for BRCA mutation testing: a comparison of available methods.
    J Clin Oncol, 24(4): 707-15. [Abstract] [Full-text]
14. Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel.
    J Clin Oncol, 24(4): 579-86. [Abstract] [Full-text]
15. Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission.
    J Clin Oncol, 24(4): 571-8. [Abstract] [Full-text]

© 2004-2008 Ovarian Cancer Research Today. All Rights Reserved.